Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 917165 | ISIN: DK0015998017 | Ticker-Symbol: BV3
Tradegate
03.05.24
14:41 Uhr
21,120 Euro
+0,180
+0,86 %
1-Jahres-Chart
BAVARIAN NORDIC A/S Chart 1 Jahr
5-Tage-Chart
BAVARIAN NORDIC A/S 5-Tage-Chart
RealtimeGeldBriefZeit
20,78021,09012:46
20,85021,02003.05.
GlobeNewswire (Europe)
231 Leser
Artikel bewerten:
(1)

Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, March 12, 2024 - Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company's shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523.

The transactions concern the vesting of restricted stock units (RSUs) including matching shares awarded to members of the Company's Executive Management in 2021 in accordance with the decision by the Board of Directors to defer part of the annual cash bonus related to their performance in 2020 by conversion into RSUs. The three-year vesting period has now expired, and all conditions for release of the shares, including matching shares, have been met.

1.Details of the person discharging managerial responsibilities/person closely associated
a)NamePaul Chaplin
2.Reason for the notification
a)Position/status

President and Chief Executive Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Shares


DK0015998017
b)Nature of the transactionAcquisition of shares (vesting of restricted stock units)
c)Price(s) and volume(s)Price(s)Volume(s)
DKK 148.178,258
d)Aggregated information
  • Aggregated volume
  • Price


8,258
DKK 1,223,570.00
e)Date of the transaction2024-03-12
f)Place of the transactionOutside a trading venue

1.Details of the person discharging managerial responsibilities/person closely associated
a)NameHenrik Juuel
2.Reason for the notification
a)Position/status

Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Shares


DK0015998017
b)Nature of the transactionAcquisition of shares (vesting of restricted stock units)
c)Price(s) and volume(s)Price(s)Volume(s)
DKK 148.184,992
d)Aggregated information
  • Aggregated volume
  • Price


4,992
DKK 739,694.00
e)Date of the transaction2024-03-12
f)Place of the transactionOutside a trading venue

1.Details of the person discharging managerial responsibilities/person closely associated
a)NameJean-Christophe May
2.Reason for the notification
a)Position/status

Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Shares


DK0015998017
b)Nature of the transactionAcquisition of shares (vesting of restricted stock units)
c)Price(s) and volume(s)Price(s)Volume(s)
DKK 148.213,987
d)Aggregated information
  • Aggregated volume
  • Price


3,987
DKK 590,917.00
e)Date of the transaction2024-03-12
f)Place of the transactionOutside a trading venue

1.Details of the person discharging managerial responsibilities/person closely associated
a)NameLaurence De Moerlooze
2.Reason for the notification
a)Position/status

Executive Vice President and Chief Medical Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Shares


DK0015998017
b)Nature of the transactionAcquisition of shares (vesting of restricted stock units)
c)Price(s) and volume(s)Price(s)Volume(s)
DKK 148.162,991

d)Aggregated information
  • Aggregated volume
  • Price


2,991
DKK 443,144.00
e)Date of the transaction2024-03-12
f)Place of the transactionOutside a trading venue

About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.

Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

Company Announcement no. 05 / 2024

Attachment

  • 2024-05-en (https://ml-eu.globenewswire.com/Resource/Download/7780bd45-233d-4b51-aa30-0193adaae812)

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.